Posts By Alex
-
530Wire StoriesHighField Biopharmaceuticals Doses First Patient in Phase 1 Trial of HFK1, a Unique Immunoliposome, for Treatment of HER2 low and HER2+ Cancers
The company’s groundbreaking drug encapsulated immunoliposomes may represent a significant improvement over existing antibody drug conjugates HANGZHOU, China–(BUSINESS WIRE)–HighField Biopharmaceuticals, a clinical...
-
454Wire StoriesBiocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors
BEIJING & BARCELONA, Spain–(BUSINESS WIRE)–#ADC–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotech company focusing on the discovery and development...
-
499Wire StoriesTikehau Capital and Nikko Asset Management Enter Into Advanced Discussion to Form a Strategic Partnership in Asia
PARIS–(BUSINESS WIRE)–Regulatory News: Tikehau Capital (Paris:TKO), the global alternative asset management group, and Nikko Asset Management, one of Asia’s largest asset...
-
444Wire StoriesMitsui Chemicals Develops Diffrar™ Optical Polymer Wafers for AR Glasses
The Lineup includes the world’s first 8-inch polymer wafer for AR glasses TOKYO–(BUSINESS WIRE)–Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO...
-
372Wire StoriesBELFOR Expands Service Portfolio in Thailand with TBCC
BANGKOK–(BUSINESS WIRE)–#BELFOR–BELFOR Thailand, the local arm of the global leader in damage restoration services, is set to diversify its operations by acquiring...
-
347Wire Stories
InnoCare Appoints Xin Fu as Chief Financial Officer
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that the Company...
-
358Wire StoriesLydia AI Expands Reach in Korea Through Strategic Partnerships with Hecto Data and Tobecon
SEOUL, South Korea–(BUSINESS WIRE)–#canada–Lydia AI, a leading Canadian health AI company, is thrilled to announce its strategic collaborations with Hecto Data and...
-
499Wire Stories
InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-332 Meet Primary Endpoint in Patients with Atomic Dermatitis
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today...
-
689BusinessMaximizing Operational Efficiency: Strategies for Manufacturing Success
Operational efficiency is defined as the ability of an organization to use its resources effectively to produce maximum output with minimal input....
-
762Wire StoriesFARFETCH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Farfetch Limited and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has...
